IGF1R and neoplasm: Aberrant fusion products, such as EWS-WT1 or EWS-FLI, the genetic hallmarks of desmoplastic small round cell tumor or Ewing sarcoma, were found to act as transactivators for the IGF-1R system, providing a selective growth advantage to tumor cells [31, 32].